Cordarone Injection 3 ml Ampoule

babies: not applicable. lactating mothers: it is unsafe to use during breastfeeding as it harms your baby.
consult your physician before using this medicine. pregnancy: it is unsafe to use in pregnancy as it causes harm to the fetus.
it is used only when the benefits outweigh the risks. consult your physician before using this medicine.
driving: it is unsafe to drive as this medication causes blurred vision after taking it. drive only after vision gets clear.
alcohol: consult your doctor before taking alcohol with this medication. kidney: it is safe to use in kidney diseases.
liver: it is safe to use in liver diseases..

Decreased blood pressure Blurred vision Slow heart rate Fatigue Nausea and vomiting Headache Chest pain Wheezing Redness, swelling and inflammation at the injection site.

Cordarone injection is an antiarrhythmic drug. It works by regulating electrical signals in the heart that causes irregular heartbeats..

If a dose of CORDARONE is missed consult your doctor immediately, don’t self administer the dose..

• Cordarone injection is an antiarrhythmic drug used to treat life-threatening conditions • you should receive it under the supervision of your doctor • avoid skipping doses as it causes severe life-threatening heart blocks • this medicine causes blurring of vision, so avoid driving and handling machinery after taking this medication • avoid excessive exposure to sunlight or use sunscreen and wear protective clothing as this medicine makes the skin sensitive to sunlight • avoid grapefruit juice with this medication as it causes unwanted side effects.

contraindicated • amiodarone hydrochloride + cisapride: concurrent use may result in an increased risk of qt interval prolongation • amiodarone hydrochloride + ketoconazole: concurrent use may result in increased amiodarone plasma concentration and an increased risk of cardiogenic toxicity • amiodarone hydrochloride + ritonavir: concurrent use may result in an increased risk of amiodarone toxicity • amiodarone hydrochloride + sparfloxacin: concurrent use may result in an increased risk of qt interval prolongation major • amiodarone hydrochloride + amitriptyline: concurrent use may result in an increased risk of qt interval prolongation and torsades de pointes • amiodarone hydrochloride + atazanavir: concurrent use may result in an increased risk of qt interval prolongation and torsades de pointes • amiodarone hydrochloride + carvedilol: concurrent use may result in increased carvedilol concentration and increased risk of heart block • amiodarone hydrochloride + ciprofloxacin: concurrent use may result in an increased risk of qt interval prolongation and torsades de pointes moderate • amiodarone hydrochloride + atorvastatin: concurrent use may result in an increased risk of myopathy • amiodarone hydrochloride + celecoxib: concurrent use may result in increased plasma levels of celecoxib minor • amiodarone hydrochloride + budesonide: concurrent use may result in an increased risk of developing cushing's syndrome.